Celtaxsys, a clinical stage drug development firm and ATDC Graduate Company, said it received U.S. Food and Drug Administration (FDA) clearance to
Celtaxsys secures $40 million in Series D financing
Celtaxsys, a clinical stage drug development firm and ATDC Graduate Company, said it successfully completed its $40 million Series D financing. Domain
CYSTIC FIBROSIS FOUNDATION AWARDS $5 MILLION TO CELTAXSYS
The Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) awarded $5 million to Celtaxsys, a clinical stage drug development firm focused on advancing
Celtaxsys gets special FDA designation for cystic fibrosis drug
Celtaxsys, a clinical-stage biotech firm and Graduate Company of the Advanced Technology Development Center at Georgia Tech, received Orphan Drug